Last reviewed · How we verify

NCT05377970

Implementation of a Prehabilitation Program for Surgical Patients

Status unknown NA Last updated 24 October 2023
What this trial tests

NA trial testing Thinkific Prehabilitation Exercise Program in Prehabilitation in 20 participants. Status unknown.

Timeline
25 June 2022
Primary endpoint
30 June 2024
31 July 2024

Quick facts

Lead sponsorMaineHealth
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment20
Start date25 June 2022
Primary completion30 June 2024
Estimated completion31 July 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

MaineHealth — full company profile →

Who can join

18 and older, any sex, with Prehabilitation or Oncology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Frailty is a state of increased vulnerability to stressors with increased rates of poor outcomes. Surgery is one of these stressors, and previous research has therefore shown increased rates of morbidity and mortality in frail patients undergoing surgery. Prehabilitation programs can help mitigate the negative outcomes associated with frailty. The investigators hope to implement a newly developed prehabilitation pilot program in the Maine Medical Center Surgical Oncology Clinic to initially evaluate adherence, self-efficacy, and health-related quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prehabilitation

Currently open trials in the same condition.

Other MaineHealth trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing